Does NADOLOL Cause Female genital tract fistula? 183 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 183 reports of Female genital tract fistula have been filed in association with NADOLOL (Nadolol). This represents 9.7% of all adverse event reports for NADOLOL.
183
Reports of Female genital tract fistula with NADOLOL
9.7%
of all NADOLOL reports
0
Deaths
182
Hospitalizations
How Dangerous Is Female genital tract fistula From NADOLOL?
Of the 183 reports, 182 (99.5%) required hospitalization, and 1 (0.5%) were considered life-threatening.
Is Female genital tract fistula Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for NADOLOL. However, 183 reports have been filed with the FAERS database.
What Other Side Effects Does NADOLOL Cause?
Drug ineffective (989)
Macular degeneration (781)
Off label use (330)
Weight decreased (324)
Nausea (295)
Dyspepsia (263)
Abdominal pain (259)
Therapeutic product effect incomplete (251)
Pain (244)
Malaise (241)
What Other Drugs Cause Female genital tract fistula?
ADALIMUMAB (437)
METRONIDAZOLE (254)
VEDOLIZUMAB (247)
INFLIXIMAB (237)
ACETAMINOPHEN (235)
PREDNISONE (231)
HYDROCORTISONE (229)
FLUTICASONE (227)
HYDROMORPHONE (227)
CLARITHROMYCIN (225)
Which NADOLOL Alternatives Have Lower Female genital tract fistula Risk?
NADOLOL vs NADROPARIN
NADOLOL vs NAFARELIN
NADOLOL vs NAFCILLIN
NADOLOL vs NAFCILLIN\NAFCILLIN
NADOLOL vs NAFRONYL